The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Vascular Solutions's revenues will grow 10.8% and EPS will grow 7.1%.
The average estimate for revenue is $26.4 million. On the bottom line, the average EPS estimate is $0.15.
Last quarter, Vascular Solutions reported revenue of $25.3 million. GAAP reported sales were 15% higher than the prior-year quarter's $22.1 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.22. GAAP EPS of $0.18 for Q4 were 38% higher than the prior-year quarter's $0.13 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 67.2%, 150 basis points better than the prior-year quarter. Operating margin was 18.0%, 240 basis points better than the prior-year quarter. Net margin was 12.1%, 230 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $108.8 million. The average EPS estimate is $0.67.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 97 members out of 108 rating the stock outperform, and 11 members rating it underperform. Among 26 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 22 give Vascular Solutions a green thumbs-up, and four give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Vascular Solutions is outperform, with an average price target of $17.10.
Is Vascular Solutions the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Vascular Solutions to My Watchlist.